Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22XIE+YONGLI%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22XIE+YONGLI%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22XIE+YONGLI%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (4)
1
Clinical characteristics associated with recurrent viral RNA positivity in patients within two weeks after recovering from the first SARS-CoV-2 infection
enthalten in:
Biomolecules & biomedicine
| 2024
von
Cao, X.
|
Xie, Y.
|
Zhou, C.
| +1
Wird geladen...
2
Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors
enthalten in:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
| 2023
von
Ma, L.
|
Li, Y.
|
Shi, T.
| +12
Wird geladen...
3
Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CLpro
enthalten in:
International journal of molecular sciences
| 2022
von
Ma, L.
|
Xie, Y.
|
Zhu, M.
| +8
Wird geladen...
4
Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro
enthalten in:
Antiviral research
| 2022
von
Ma, L.
|
Li, Q.
|
Xie, Y.
| +7
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
4
Aufsätze
4
E-Artikel
4
E-Ressourcen
Zeitschriftentitel
1
Antiviral research
1
Biomedicine & pharmacotherapy = Biomedecine & p...
1
Biomolecules & biomedicine
1
International journal of molecular sciences
Thema
4
Journal Article
2
Antiviral Agents
2
Coronavirus 3C Proteases
2
EC 3.4.22.-
2
EC 3.4.22.28
2
Protease Inhibitors
1
3C-like proteinase, SARS-CoV-2
1
3CLpro
1
61036-62-2
1
9WS5RD66HZ
1
Angiotensin converting enzyme 2
1
Angiotensin-Converting Enzyme 2
1
Anti-Bacterial Agents
1
Anti-coronavirus drug
1
Cysteine Endopeptidases
1
Darunavir
1
EC 3.4.17.23
1
Entry inhibitor
1
HIV Protease Inhibitors
1
Interleukin-6
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
1
2023
2
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4
Englisch
Haven't found what you're looking for?
Wird geladen...